In a letter to The Lancet, Dr Gillon and colleagues called for a study of acute post-transfusion NANB Hepatitis in the UK and stated that surrogate screening was not justified at the time.
Chronology Information
Date:
Chapter/issue
Hepatitis C Surrogate Screening
Key Person(s)
Dr Brian Charles Dow
Dr Eddie A C Follett
Dr Ruthven Mitchell
Dr John Gillon